This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Rohaan, M. W. et al. Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma. N. Engl. J. Med. 387, 2113–2125 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Efficacy of TILs confirmed. Nat Rev Clin Oncol 20, 64 (2023). https://doi.org/10.1038/s41571-022-00723-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00723-0